Zymeworks (ZYME) Completes Theravance Biopharma Acquisition, Eyes Growth in COPD Market

gurufocus.com · 2026-09-28

On September 28, 2026, Zymeworks Inc (NASDAQ: ZYME) finalized its acquisition of Theravance Biopharma, a strategic move expected to boost revenue and cash flow

Read the full story at gurufocus.com →